Universal Health Services

NYSE
UHS
Stock
Yield per half year: -9.65%
Dividend yield: 0.4068%
Sector: Healthcare

Company Analysis Universal Health Services

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (186.21 $) is less than fair price (203.03 $)
  • The stock's return over the last year (5.58%) is higher than the sector average (-21.87%).
  • Current debt level 34.25% is below 100% and has decreased over 5 years from 36.93%.
  • The company's current efficiency (ROE=17.71%) is higher than the sector average (ROE=-83.36%)

Disadvantages

  • Dividends (0.4068%) are below the sector average (1.26%).

Similar companies

Humana

AbbVie

PFIZER

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Universal Health Services Healthcare Index
7 days -5.4% -43.1% 1.6%
90 days 2.6% -21% 4.7%
1 year 5.6% -21.9% 12.2%

UHS vs Sector: Universal Health Services has outperformed the "Healthcare" sector by 27.45% over the past year.

UHS vs Market: Universal Health Services has significantly underperformed the market by -6.64% over the past year.

Stable price: UHS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: UHS with weekly volatility of 0.1073% over the past year.

3. Summary of the report

3.1. General

P/E: 10.6
P/S: 0.7651

3.2. Revenue

EPS 16.82
ROE 17.71%
ROA 8.03%
ROIC 9.48%
Ebitda margin 14.31%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (186.21 $) is lower than the fair price (203.03 $).

Price not significantly lower than the fair price: The current price (186.21 $) is slightly lower than the fair price by 9%.

4.2. P/E

P/E vs Sector: The company's P/E (10.6) is lower than that of the sector as a whole (53.14).

P/E vs Market: The company's P/E (10.6) is lower than that of the market as a whole (62.2).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.79) is lower than that of the sector as a whole (10.86).

P/BV vs Market: The company's P/BV (1.79) is lower than that of the market as a whole (20.84).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.7651) is lower than that of the sector as a whole (4.06).

P/S vs Market: The company's P/S indicator (0.7651) is lower than that of the market as a whole (16.02).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (7.48) is lower than that of the sector as a whole (16.98).

EV/Ebitda vs Market: The company's EV/Ebitda (7.48) is lower than that of the market as a whole (27.16).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 4.2% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.2%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.32%).

5.4. ROE

ROE vs Sector: The company's ROE (17.71%) is higher than that of the sector as a whole (-83.36%).

ROE vs Market: The company's ROE (17.71%) is lower than that of the market as a whole (43.08%).

5.5. ROA

ROA vs Sector: The company's ROA (8.03%) is higher than that of the sector as a whole (6.41%).

ROA vs Market: The company's ROA (8.03%) is lower than that of the market as a whole (23.27%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (9.48%) is lower than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (9.48%) is higher than that of the market as a whole (9.29%).

6. Finance

6.1. Assets and debt

Debt level: (34.25%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 36.93% to 34.25%.

Excess of debt: The debt is not covered by net income, percentage 433.89%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0.4068% is below the average for the sector '1.26%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 0.4068% has been steadily paid over the past 7 years, DSI=0.93.

Weak dividend growth: The company's dividend yield 0.4068% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (4.67%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Universal Health Services

9.3. Comments